T1	Participants 40 74	children and young adults with HIV
T2	Participants 172 193	HIV-infected patients
T3	Participants 516 637	perinatally acquired HIV (PHIV)-infected subjects or behaviorally acquired HIV (BHIV)-infected subjects (5.0-24.9 years).
